Blog

Discover how effective topical JAK inhibitors offer new relief for chronic hand eczema, improving symptoms and quality of life for...

Discover how tildrakizumab is gaining traction among older patients with plaque psoriasis, as new research highlights its benefits and effectiveness...

FDA grants Priority Review for brepocitinib, a promising treatment for dermatomyositis. Discover the latest updates on this groundbreaking therapy and...

Discover how the IL-23 inhibitor tildrakizumab improves care continuity for Medicare psoriasis patients, enhancing treatment persistence and outcomes.

Discover difamilast ointment, a new non-steroidal treatment for atopic dermatitis. Learn how this PDE4 inhibitor offers relief for mild to...

Stay updated with the February 2026 Dermatology Update, featuring key FDA approvals, including Galderma's relabotulinumtoxinA for wrinkles and AbbVie's vitiligo...

Discover innovative biologic treatment strategies for Hidradenitis Suppurativa, addressing complex patient needs and improving long-term outcomes in dermatology.

Discover how abrocitinib provides rapid relief for patients with itch-dominant atopic dermatitis, improving quality of life in this crucial analysis.